Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Original Research

Published on 17 Dec 2024

Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p

in Cancer Molecular Targets and Therapeutics

Guodong Huang
Yuxia Liu
Lisha Li
Bing Li
Ting Jiang
Yufeng Cao
Xiaoping Yang
Xinning Liu
Honglin Qu
Shitao Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1508715

967 views

Review

Published on 16 Dec 2024

Unraveling IFI44L’s biofunction in human disease

in Cancer Molecular Targets and Therapeutics

Juan Du
Hui Luo
Shuang Ye
Hui Zhang
Zhen Zheng
Kaitai Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1436576

1,293 views
1 citation

Original Research

Published on 16 Dec 2024

Hyaluronic acid–targeted topotecan liposomes improve therapeutic efficacy against lung cancer in animals

in Cancer Molecular Targets and Therapeutics

Gangqiang Xue
Lu Tang
Xinyan Pan
Sanni Li
Juan Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1520274

711 views

Review

Published on 16 Dec 2024

Research progress and treatment status of malignant ascites

in Cancer Molecular Targets and Therapeutics

Jing He
Hui-ping Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1390426

1,127 views

Mini Review

Published on 13 Dec 2024

ILF2: a multifaceted regulator in malignant tumors and its prospects as a biomarker and therapeutic target

in Cancer Molecular Targets and Therapeutics

Tonglin Sun
Xi Li
Yi Zhang
Bingwen Zou
Yan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1513979

1,304 views

Review

Published on 12 Dec 2024

Molecular glue degrader for tumor treatment

in Cancer Molecular Targets and Therapeutics

Yuhan Hu
Yan Yan
Jiehao Wang
Jiangxue Hou
Quande Lin

Frontiers in Oncology

doi 10.3389/fonc.2024.1512666

2,841 views
2 citations

Correction

Published on 11 Dec 2024

Corrigendum: Radiotherapy and breast cancer: finally, an lncRNA perspective on radiosensitivity and radioresistance

in Cancer Molecular Targets and Therapeutics

Fatemeh Yazarlou
Ivan Martinez
Leonard Lipovich

Frontiers in Oncology

doi 10.3389/fonc.2024.1507032

488 views

Original Research

Published on 06 Dec 2024

Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11

in Cancer Molecular Targets and Therapeutics

Vid Mlakar
Ina Oehme
Laurence Lesne
Sara Najafi
Marc Ansari
Fabienne Gumy-Pause

Frontiers in Oncology

doi 10.3389/fonc.2024.1433256

1,209 views

Review

Published on 05 Dec 2024

Advances in DLL3-targeted therapies for small cell lung cancer: challenges, opportunities, and future directions

in Cancer Molecular Targets and Therapeutics

Jianhua Ding
Chaihong Yeong

Frontiers in Oncology

doi 10.3389/fonc.2024.1504139

3,149 views
3 citations

Review

Published on 04 Dec 2024

Targeting the SMURF2-HIF1α axis: a new frontier in cancer therapy

in Cancer Molecular Targets and Therapeutics

Emile Youssef
Shuai Zhao
Connor Purcell
Gary L. Olson
Wafik S. El-Deiry

Frontiers in Oncology

doi 10.3389/fonc.2024.1484515

2,624 views
3 citations

Review

Published on 03 Dec 2024

The role of N6-methyladenosine modification in tumor angiogenesis

in Cancer Molecular Targets and Therapeutics

Lifei Qin
Xinya Zeng
Xinze Qiu
Xingmei Chen
Shiquan Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1467850

1,001 views

Original Research

Published on 02 Dec 2024

Metabolomics and network pharmacology–guided analysis of TNF-α expression by Argemone mexicana (Linn) targeting NF-kB the signalling pathway in cancer cell lines

in Cancer Molecular Targets and Therapeutics

Sunanda Kulshrestha
Anjana Goel
Subhadip Banerjee
Rohit Sharma
Mohammad Rashid Khan
Kow-Tong Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1502819

1,538 views
1 citation

Review

Published on 29 Nov 2024

Crosstalk between lactate and tumor-associated immune cells: clinical relevance and insight

in Cancer Molecular Targets and Therapeutics

Kemin Sun
Ye Shen
Xiang Xiao
Hao Xu
Quanli Zhang
Ming Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1506849

1,271 views
1 citation

Systematic Review

Published on 29 Nov 2024

Circular RNA CDR1as/ciRS-7– a novel biomarker in solid tumors

in Cancer Molecular Targets and Therapeutics

Yun Zhang
Chanyu Xiong
Zhilin Jiang
Xiao Wang
Juanjuan Ji
Yan Pan
Tianshu Yu
Zihao Wang
Lin Zhu
Yumei Yue

Frontiers in Oncology

doi 10.3389/fonc.2024.1468363

944 views

Original Research

Published on 29 Nov 2024

The role of ATP6V0D2 in breast cancer: associations with prognosis, immune characteristics, and TNBC progression

in Cancer Molecular Targets and Therapeutics

Jingyu Zhang
Lixian Yang
Bin Xu
Haibo Ji
Shuo Liu
Xiaohan Wang
Xiaolong Li
Quanle Wang
Zhenchuan Song

Frontiers in Oncology

doi 10.3389/fonc.2024.1511810

1,176 views
1 citation

Original Research

Published on 27 Nov 2024

EGFR and MUC1 as dual-TAA drug targets for lung cancer and colorectal cancer

in Cancer Molecular Targets and Therapeutics

Huilin Cui
Qianqian Yu
Qumiao Xu
Chen Lin
Long Zhang
Wei Ye
Yifei Yang
Sijia Tian
Yilu Zhou
Runzhe Sun

Frontiers in Oncology

doi 10.3389/fonc.2024.1433033

1,784 views